ICVTS Click here to goto Smart Canula website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael Brandt
Gustav Steinhoff
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandt, M.
Right arrow Articles by Steinhoff, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandt, M.
Right arrow Articles by Steinhoff, G.
Related Collections
Right arrow Lung - transplantation
Interactive Cardiovascular and Thoracic Surgery 2:509-513(2003)
© 2003 European Association of Cardio-Thoracic Surgery

Work in progress report - Experimental

Prevention of lung allograft rejection by combined treatment with adhesion molecule antibodies and cyclosporine

Michael Brandta,*, Christian Grotkopa, Jörg Steinmannb and Gustav Steinhoffa

a Department of Cardiovascular Surgery, University-Hospital, Arnold-Heller-Strasse 7, 24105 Kiel, Germany
b Institute of Immunology, University-Hospital, Arnold-Heller-Strasse 7, 24105 Kiel, Germany

* Corresponding author. Tel.: +49-431-597-4401; fax: +49-431-597-4402
mbrandt{at}kielheart.uni-kiel.de

Infiltration of leukocytes into the lung allograft is regulated by adhesion molecules during acute rejection. The purpose of this study was to assess the effect of monoclonal antibodies against ICAM-1 (1A29) to prevent rejection after lung transplantation. Left lateral orthotopic lung transplantation was performed using Dark Agouti rats as donors and Lewis rats as recipients. Recipients received 1A29 alone (group A), cyclosporine A alone (group B), a combination of both drugs (group C) or no therapy (group D). Animals were killed on day 5 and 10, respectively. Rejection was graded by histology. Myeloperoxidase activity (MPO) was measured in the graft. In allografts treated with cyclosporine and 1A29 histologically a lower grade of rejection was seen and less MPO were detected compared to groups A, B and D. Anti-ICAM-1 monoclonal antibodies alone as well as a subtherapeutic dose of cyclosporine are not effective to prevent acute allograft rejection after lung transplantation. However, the combination of both strategies significantly reduces rejection in this model.

Key Words: Adhesion molecule; Monoclonal antibody; Rat lung transplantation; Cyclosporine; Rejection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 European Association for Cardio-thoracic Surgery